Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 276

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Crizotinib in Anaplastic Large-Cell Lymphoma

Open access
Gambacorti-Passerini, Carlo, Messa, Cristina, Pogliani, Enrico M. · 2011 · New England Journal of Medicine

Abstract

Crizotinib in Anaplastic Large-Cell LymphomaTo the Editor: Crizotinib, an inhibitor of the anaplastic lymphoma kinase (ALK) tyrosine kinase, is active in non-small-cell lung cancers that have ALK expression. 1 ALK is fused to several partner genes (mainly the gene encoding nucleophosmin) in the majority of anaplastic large-cell lymphomas (ALCLs).ALK tyrosine kinase activity represents the driver alteration in this disease. 2ALK-positive ALCLs are highly responsive to cytotoxic drugs.However, relapses occur and require salvage therapy.We treated two patients who had relapsed ALK-positive ALCL with crizotinib at a dose of 250 mg twice daily.No glucocorticoids or other drugs with antineoplastic activity were allowed.Patient 1, a 26-year-old woman, received seven cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP-15) and had a partial response at 1 month.She was subsequently treated with standard salvage combination chemotherapy regimens in an attempt to prepare for autologous bone marrow transplantation.However, relapse occurred within 2 to 3 weeks after each regimen.Pretreatment evaluation included fever (temperatures >38°C), cervical and inguinal adenopathy, and positive results on positron-emission tomographic (PET) and computed tomographic (CT) images of paraaortic and iliac nodes; bone marrow aspiration showed 3% of cells with ALK rearrangement.She had a score of 3 on the Eastern Cooperative Oncology Group (ECOG) performance scale (indicating confinement to bed or chair 50% or more of waking hours).After the initiation of crizotinib, Patient 1's fever disappeared within 48 hours; by day 7, all palpable adenopathy had resolved.PET and CT images and bone marrow aspiration performed at 28 days showed complete regression of previous

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc1013224

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 276

Metadata

Authors
Gambacorti-Passerini, C., Messa, C., & Pogliani, E. M.
Venue
New England Journal of Medicine
Published
2011-02-24
Volume
364
Issue
8
Pages
775-776
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1990487163
Cited by
276
References
2
FWCI
24.41
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.